跳至主要内容
临床试验/EUCTR2017-000368-14-SE
EUCTR2017-000368-14-SE进行中(未招募)1 期

A head-to-head randomized clinical trial of methylphenidate and lisdexamphetamine treatment for executive functions and global functioning in adults with ADHD - A clinical trial with two psychostimulants of Central Nervous System in adults with ADHD

Sahlgrenska Univerisity Hospital Gothenburg0 个研究点目标入组 120 人开始时间: 2017年3月30日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Adults 18-45 years of age
  • Clinical diagnosis ADHD of any subtype and DSM 5 presentation
  • Intellectual ability in the normal range, according to clinical judgment
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 120
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Physical or mental limitations that make cognitive evaluations unsuitable.
  • Cardiovascular disease, seizures or other unstable medical conditions that might increase the risk for the subject.
  • Bipolar Disorder, Conduct Disorder, Psychosis, severe autism or other severe comorbid or medical conditions that in the investigator's opinion would make study participation unsuitable.
  • Substance abuse.
  • Subjects who has previously been treated with ADHD medication.

研究者

发起方
Sahlgrenska Univerisity Hospital Gothenburg

相似试验